Search by Drug Name or NDC
NDC 29300-0382-05 Carbamazepine 200 mg/1 Details
Carbamazepine 200 mg/1
Carbamazepine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Unichem Pharmaceuticals (USA), Inc.. The primary component is CARBAMAZEPINE.
Product Information
| NDC | 29300-0382 |
|---|---|
| Product ID | 29300-382_d4ccdef2-d0be-4c67-9123-885b064ea3b8 |
| Associated GPIs | |
| GCN Sequence Number | 004558 |
| GCN Sequence Number Description | carbamazepine TABLET 200 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 17450 |
| HICL Sequence Number | 001893 |
| HICL Sequence Number Description | CARBAMAZEPINE |
| Brand/Generic | Generic |
| Proprietary Name | Carbamazepine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Carbamazepine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | CARBAMAZEPINE |
| Labeler Name | Unichem Pharmaceuticals (USA), Inc. |
| Pharmaceutical Class | Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mo |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213284 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 29300-0382-05 (29300038205)
| NDC Package Code | 29300-382-05 |
|---|---|
| Billing NDC | 29300038205 |
| Package | 500 TABLET in 1 BOTTLE (29300-382-05) |
| Marketing Start Date | 2022-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |